Singapore markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
67.72+0.30 (+0.44%)
At close: 04:00PM EDT
67.72 0.00 (0.00%)
After hours: 07:58PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
6,166,000
6,329,000
7,832,000
5,369,000
Other short-term investments
239,000
69,000
160,000
849,000
Total cash
6,405,000
6,398,000
7,992,000
6,218,000
Net receivables
10,521,000
9,644,000
7,022,000
5,761,000
Inventory
4,699,000
8,983,000
4,024,000
3,193,000
Other current assets
-
105,000
-
-
Total current assets
22,593,000
26,244,000
19,544,000
15,563,000
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
9,449,000
10,171,000
8,917,000
8,335,000
Accumulated depreciation
-7,743,000
-8,324,000
-8,193,000
-7,517,000
Net property, plant and equipment
9,449,000
10,171,000
8,917,000
8,335,000
Goodwill
19,820,000
19,997,000
11,845,000
11,668,000
Intangible assets
39,307,000
42,387,000
20,947,000
20,833,000
Total non-current assets
73,890,000
79,119,000
47,185,000
45,814,000
Total assets
96,483,000
105,363,000
66,729,000
61,377,000
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
5,314,000
1,660,000
2,194,000
1,822,000
Accounts payable
19,040,000
18,938,000
15,785,000
13,987,000
Total current liabilities
26,293,000
22,594,000
20,307,000
18,117,000
Non-current liabilities
Long-term debt
22,965,000
28,134,000
17,505,000
15,730,000
Deferred tax liabilities
2,944,000
6,206,000
2,918,000
2,490,000
Deferred revenues
14,000
26,000
38,000
50,000
Total non-current liabilities
33,132,000
43,482,000
30,784,000
28,664,000
Total liabilities
59,425,000
66,076,000
51,091,000
46,781,000
Stockholders' equity
Common stock
387,000
387,000
328,000
328,000
Retained earnings
-574,000
1,710,000
5,299,000
2,812,000
Total stockholders' equity
37,037,000
39,268,000
15,622,000
13,127,000
Total liabilities and stockholders' equity
96,483,000
105,363,000
66,729,000
61,377,000